Stocks
Health Care
sls
SELLAS Life Sciences Group
NASDAQ: SLS
-0.17 (-4.33%)
3.865
USD
At close at Jan 08, 21:42 UTC
Income Statement
Revenue
-
Gross Profit
-
Operating Income
-31.51M
Pretax Income
-25.94M
Net Income
-30.88M
EBITDA
-30.32M
EBIT
-30.88M
Earnings Per Share
-0.5199999999999999
Balance Sheet
Cash & Cash Equivalents
15.72M
Total Debt
767.50K
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
9.49M
Book Value Per Share
0.15
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.